About two years after signing a partnership for protein optimization with Eli Lilly and Co. - and less than a week after filing its first investigational new drug application for a compound being developed in-house - Applied Molecular Evolution Inc. has agreed to merge with Lilly in a deal expected to be worth about $400 million, net of cash. (BioWorld Today) Read More
